Glaxo Adds Heart Attack Warning To Avandia
GlaxoSmithKline has added a "black box" to the diabetes medication Avandia warning about possible heart problems, acknowledging that the U.S. Food and Drug Administration's studies could not exclude the risks the...To view the full article, register now.
Already a subscriber? Click here to view full article